Učitavanje...

Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice

BACKGROUND: Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer eff...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Park, Hae-Ran, Ju, Eun-Jin, Jo, Sung-Kee, Jung, Uhee, Kim, Sung-Ho, Yee, Sung-Tae
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2666758/
https://ncbi.nlm.nih.gov/pubmed/19292900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-85
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!